Location History:
- Eschbach, DE (2008 - 2011)
- Basel, CH (2017)
Company Filing History:
Years Active: 2008-2017
Title: The Innovations of Ernst Kuesters
Introduction
Ernst Kuesters is a notable inventor based in Eschbach, Germany. He has made significant contributions to the field of chemical processes, particularly in the preparation of complex compounds. With a total of four patents to his name, Kuesters has demonstrated a commitment to advancing scientific knowledge and innovation.
Latest Patents
Kuesters' latest patents include a chemical process for preparing spiroindolones and intermediates thereof. This invention relates to processes and intermediates useful for the manufacture of spiroindolone compounds, such as (1'R,3'S)-5,7'-dichloro-6'-fluoro-3'-methyl-2',3',4',9'-tetrahydrospiro[indoline-3,1'-pyrido[3,4-b]indol]-2-one and its salts, hydrates, and solvates. Another significant patent involves processes for the preparation of 4-oxo-octahydro-indole-1-carbocyclic acid methyl ester and its derivatives. This invention focuses on the production of carbamic acid (2-chloroethyl)(3-oxocyclohexyl)-alkyl ester enantiomers and 1-carbalkoxy-4-ketoperhydroindole enantiomers.
Career Highlights
Ernst Kuesters is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore innovative solutions in the pharmaceutical industry. Kuesters' expertise in chemical processes has positioned him as a valuable asset in the development of new therapeutic compounds.
Collaborations
Throughout his career, Kuesters has collaborated with esteemed colleagues, including Gottfried Sedelmeier and Michael Crowe. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their respective fields.
Conclusion
Ernst Kuesters is a distinguished inventor whose work in chemical processes has led to significant advancements in the pharmaceutical industry. His contributions, particularly in the preparation of complex compounds, highlight his dedication to innovation and scientific progress.